首页> 外文期刊>Urology >Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
【24h】

Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.

机译:von Hippel-Lindau病的保肾手术后局部复发。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To evaluate the risks of local recurrence and repeat surgery after nephron-sparing surgery (NSS) in von Hippel-Lindau (VHL) disease to propose a therapeutic strategy to patients. METHODS: A total of 21 patients with VHL disease and renal tumors were followed up from February 1987 to August 2005. Surgical resection of all tumors was chosen when the largest tumor exceeded a diameter of 30 mm. RESULTS: Of the 21 patients, 18 underwent surgery at a mean age of 38.5 years (range 24 to 69). The median follow-up of the series was 100 months. Of the 17 patients treated by NSS, 8 developed a recurrence. The mean time to local recurrence was 53 +/- 38.8 months (range 10 to 115), and the recurrence tumors grew at a stable mean rate of 0.34 +/- 0.32 cm/yr (range 0.1 to 1.08). Repeat NSS was performed on the same kidney in 2 cases and eight recurrences were kept under surveillance. The disease-specific survival rate was 93.8% at 10 years. The local recurrence rate was 45.6% at 5 years and 83.7% at 10 years. The overall repeat surgery rate was 23.1% at 5 years and 63.4% at 10 years. No metastasis or chronic renal insufficiency was observed in patients undergoing NSS only. CONCLUSIONS: Five years after NSS, the risk of developing new tumors in the same kidney and the overall risk of repeat surgery was about 50% and 25%, respectively. However, the strategy of elective NSS and close surveillance preserved renal function without increasing the risk of metastasis.
机译:目的:评估在保尔·希佩尔·林道(VHL)病患的保肾手术(NSS)后局部复发和重复手术的风险,为患者提供治疗策略。方法:自1987年2月至2005年8月,共对21例VHL病和肾肿瘤患者进行了随访。当最大肿瘤直径超过30 mm时,应选择手术切除所有肿瘤。结果:在这21例患者中,有18例接受了手术,平均年龄为38.5岁(范围为24至69岁)。该系列的中位随访时间为100个月。在接受NSS治疗的17例患者中,有8例复发。局部复发的平均时间为53 +/- 38.8个月(范围10至115),并且复发肿瘤以0.34 +/- 0.32 cm / yr(范围0.1到1.08)的稳定平均速率生长。 2例在同一肾脏重复进行NSS,并监测8例复发。在10年时,疾病特异性生存率为93.8%。 5年局部复发率为45.6%,10年局部复发率为83.7%。 5年时总体重复手术率为23.1%,10年时为63.4%。仅接受NSS的患者未观察到转移或慢性肾功能不全。结论:NSS发生五年后,同一肾脏中出现新肿瘤的风险和重复手术的总体风险分别约为50%和25%。但是,选择性NSS和密切监视的策略可以保留肾功能,而不会增加转移的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号